Search / 8 results found

from
to
  • Updated

LAKE OSWEGO, Ore., Sept. 9, 2021 /PRNewswire/ -- Following the European Society of Cardiology (ESC) Congress 2021, BIOTRONIK today announced the first observational results of the CERTITUDE registry. The registry is designed to evaluate real-world clinical outcomes of patients in the United States who use implantable loop recorders (ILR), pacemakers, implantable cardioverter-defibrillator (ICD), and cardiac resynchronization therapy (CRT-D) devices that have BIOTRONIK Home Monitoring® capability. BIOTRONIK Home Monitoring is the only monitoring system approved by the FDA for early detection and as a replacement for device interrogation during in-office follow-ups.